Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Galera Therapeutics Inc (GRTX)

Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Galera Therapeutics Inc 101 LINDENWOOD DRIVE SUITE 225 MALVERN PA 19355 USA

www.galeratx.com Employees: 3 P: 610-725-1500

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel, proprietary therapeutics to transform radiotherapy in cancer. The company's product candidate is GC4419, a highly selective and potent small molecule dismutase mimetic which is designed to rapidly convert superoxide to hydrogen peroxide. Galera Therapeutics, Inc. is headquartered in Malvern, PA.

Key Statistics

Overview:

Market Capitalization, $K 1,660
Enterprise Value, $K -6,630
Shares Outstanding, K 75,462
Float, K 65,727
% Float 87.10%
Short Interest, K 5
Short Float 0.01%
Days to Cover 1.00
Short Volume Ratio 0.02
% of Insider Shareholders 12.90%
% of Institutional Shareholders 50.77%
Annual Net Income, $ -18,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,390 K
EBIT, $ -6,160 K
EBITDA, $ -6,140 K
3-Year Return -98.95%
5-Year Return -99.81%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 98.16%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -0.10
EPS Growth vs. Prev Year 83.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

GRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -101.36%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.94
Interest Coverage -0.45
60-Month Beta 1.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar